TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

ISTITUTO BIO ITA SPA

Infectious DiseaseDermatologyGastroenterology
Generics

ISTITUTO BIO ITA SPA is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology.

1987
Since
7
Drugs
-
Trials
97
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-02-17
Labeling
AMPICILLIN AND SULBACTAM 2026-01-30
Labeling
AMPICILLIN AND SULBACTAM 2026-01-27
Labeling
AMPICILLIN AND SULBACTAM 2026-01-19
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 57%
4 drugs
Dermatology 29%
2 drugs
Gastroenterology 14%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology